Editas Medicine (EDIT) Reports In-Line Q3 EPS

FREE Breaking News Alerts from StreetInsider.com!

StreetInsider.com Top Tickers, 9/2/2026

1. PANW
2. GTLB
3. MDB
4. DELL
5. SPY

6. MMED
7. CRDO
8. AAPL
9. MDT
10. CL

Price: $3.07 --0%

Revenue Growth %: -50.4%

Today's EPS Names:
RCBC, GASS, YSG, More

Editas Medicine (NASDAQ: EDIT) reported Q3 EPS of ($0.75), in-line with the analyst estimate of ($0.75).

For earnings history and earnings-related data on Editas Medicine (EDIT) click here.

Earnings

Sign up for StreetInsider Free!

Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!